Why Researchers Are Still Testing Wild Animals for COVID-19
(Grand Portage, Minn.) — To administer this COVID test, Todd Kautz had to lay on his belly in the snow and worm his upper body into the narrow den of a hibernating black bear. Training a light on its snout, Kautz carefully slipped a long cotton swab into the bear’s nostrils five times.
For postdoctoral researcher Kautz and a team of other wildlife experts, tracking the coronavirus means freezing temperatures, icy roads, trudging through deep snow and getting uncomfortably close to potentially dangerous wildlife.
They’re testing bears, moose, deer and wolves on a Native American reservation in the remote n...
Source: TIME: Health - March 30, 2022 Category: Consumer Health News Authors: Laura Ungar / AP Tags: Uncategorized COVID-19 healthscienceclimate News Desk wire Source Type: news
U.S. FDA Approves CABENUVA (cabotegravir and rilpivirine) for Adolescents, Expanding the Indication of the First and Only Complete Long-Acting Injectable HIV Regimen
TITUSVILLE, N.J., March 29, 2022 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced the U.S. Food and Drug Administration (FDA) has approved CABENUVA (cabotegravir and rilpivirine) for the treatment of HIV-1 in virologically suppressed adolescents (HIV-1 RNA less than 50 copies per milliliter [c/mL]) who are 12 years of age or older, weigh at least 35 kg and are on a stable antiretroviral regimen, with no history of treatment failure, nor known or suspected resistance to either cabotegravir or rilpivirine.1,2 Co-developed as part of a collaboration with ViiV Healthcare, CABENUVA is the first ...
Source: Johnson and Johnson - March 30, 2022 Category: Pharmaceuticals Tags: Innovation Source Type: news
ViiV Healthcare Announces US FDA Approval of Cabenuva (cabotegravir, rilpivirine) for Virologically Suppressed Adolescents Living with HIV Who Are 12 Years of Age or Older and Weigh at Least 35 kg
Research Triangle Park, NC, March 29, 2022– ViiV Healthcare, the global specialist HIV company majority owned by GlaxoSmithKline plc (“GSK”), with Pfizer Inc. and Shionogi B.V. as shareholders, today announced that the US... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - March 29, 2022 Category: Drugs & Pharmacology Source Type: news
Why the UK can ’t rely on boosters to get through each new wave of Covid | Danny Altmann
The evidence suggests performance could be less predictable and effective in the future – though there are promising developmentsDanny Altmann is a professor of immunology at Imperial College LondonThis time in 2020, we watched with horror as the realities of the pandemic and its death toll unfurled. Most hardly dared imagine thateffective vaccines might appear in a fraction of the time taken for previous efforts, effectively stemming the pandemic tide.But despite the success of the vaccines in greatly reducing the odds of hospitalisation or death, viral evolution had plenty more to throw at us. The onslaught of highlyim...
Source: Guardian Unlimited Science - March 28, 2022 Category: Science Authors: Danny Altmann Tags: Immunology Vaccines and immunisation Coronavirus UK news Health Science Society Source Type: news
'One in 15' infected with new Covid variant, warns Dr Chris
THERE is widespread belief that the coronavirus is loosening its grip, but current data suggests otherwise. Relaxed Covid measures and the higher transmissibility of the Omicron variant could be driving a surge in Covid infections across the country, warned virologist doctor Chris on BBC Breakfast today. (Source: Daily Express - Health)
Source: Daily Express - Health - March 26, 2022 Category: Consumer Health News Source Type: news
U.S. FDA Approves Streamlined Process for Initiating HIV Therapy with CABENUVA (cabotegravir and rilpivirine), the First and Only Complete Long-Acting Injectable HIV Treatment
TITUSVILLE, N.J., March 24, 2022 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced the U.S. Food and Drug Administration (FDA) has approved a label update for CABENUVA (cabotegravir and rilpivirine), giving healthcare professionals and people living with human immunodeficiency virus (HIV-1) in the U.S. the option to start this once-monthly or every-two-month injectable treatment without the need for the oral lead-in phase (daily cabotegravir and rilpivirine tablets, taken for one month prior to initiation of cabotegravir and rilpivirine injections).1 Clinical data demonstrated the regimen di...
Source: Johnson and Johnson - March 24, 2022 Category: Pharmaceuticals Tags: Innovation Source Type: news
Top Virologist Who Visited a Wuhan Market in 2014 Said He Found
(Source: NYT Health)
Source: NYT Health - March 23, 2022 Category: Consumer Health News Authors: Carl Zimmer Source Type: news
Can we vaccinate against Epstein-Barr, the virus you didn ’t know you had?
EBV is a puzzling pathogen that lies dormant in most of us. But its link to MS – detailed in a landmark new study – and some cancers has led to the development of new vaccinesIn the 1970s, Hank Balfour, a virologist at the University of Minnesota Medical School, was studying the long-term survival prospects of kidney transplant patients when he noticed that a small proportion of them went on to develop a rare form of cancer known as post-transplant proliferative disorder.He was particularly intrigued when he discovered that almost all of these patients had been infected with a virus called Epstein-Barr or EBV, a curiou...
Source: Guardian Unlimited Science - March 20, 2022 Category: Science Authors: David Cox Tags: Science Multiple sclerosis Infectious diseases Medical research Microbiology Vaccines and immunisation Health Source Type: news
Have not spotted reverse zoonosis cases in India yet: Dr Priya Abraham, Director National Institute of Virology
"This virus is still an invisible enemy to the world. Under-vaccinated countries and regions are more susceptible. Also, it is still a problem for the elderly as well as people with comorbidities, particularly if they are unvaccinated," said Dr Priya Abraham, director of National Institute of Virology. (Source: The Economic Times)
Source: The Economic Times - March 19, 2022 Category: Consumer Health News Source Type: news
Alcohol, Smoking, Drug Use and HIV Virological Outcomes Alcohol, Smoking, Drug Use and HIV Virological Outcomes
Might alcohol, cigarette and drug use impact ART adherence and virological outcomes among people living with HIV?HIV Medicine (Source: Medscape Hiv-Aids Headlines)
Source: Medscape Hiv-Aids Headlines - March 17, 2022 Category: Infectious Diseases Tags: HIV/AIDS Journal Article Source Type: news
COVID Finally Spins Out of Control in China as New Variant Takes Hold
Cities including Shanghai and Shenzhen locked down again, but a leading Chinese virologist questions whether China can be kept COVID-free. #shenzhen #virologist (Source: Reuters: Health)
Source: Reuters: Health - March 14, 2022 Category: Consumer Health News Source Type: news
Dr Chris issues worrying warning about new Covid stats - do not be 'subverted' by figures
DR CHRIS has said people must still be wary of coronavirus, as there are still many cases in the UK. This comes following claims that Covid-19 might now be less of a threat than flu. The virologist warned: "We are still seeing a significant impact of coronavirus". (Source: Daily Express - Health)
Source: Daily Express - Health - March 12, 2022 Category: Consumer Health News Source Type: news
Covid treatment sotrovimab can cause drug-resistant mutation, study finds
Australian researchers raise concerns mutated virus could spread in the community if patients given the drug are not monitoredGet our free news app;get our morning email briefingAustralian virologists have uncovered a drug-resistant mutation in the Covid-19 virus associated with the drug sotrovimab and say without the monitoring of patients given the treatment the mutated virus could spread in the community.The world-first findings,published in the New England Journal of Medicine on Thursday, are the result of an analysis of the first 100 patients in western Sydney during the Delta outbreak in 2021 to be given sotrovimab.S...
Source: Guardian Unlimited Science - March 10, 2022 Category: Science Authors: Melissa Davey Medical editor Tags: Coronavirus Health Infectious diseases Medical research Science Australia news Source Type: news
B/F/TAF Efficacy in Those With Preexisting INSTI Resistance B/F/TAF Efficacy in Those With Preexisting INSTI Resistance
Is this HIV treatment option an effective means of achieving virologic suppression among those who are resistant to INSTI-based regimens?JAIDS: Journal of Acquired Immune Deficiency Syndromes (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - March 10, 2022 Category: Consumer Health News Tags: HIV/AIDS Journal Article Source Type: news
Covid China: Staff at Wuhan lab admit 'devastating pandemics can occur' if viruses escape
In a 2,000-word article published in a scientific journal, professors from the Wuhan Institute of Virology laid out a series of recommendations to avoid spillovers - amid fears Covid leaked from the lab. (Source: the Mail online | Health)
Source: the Mail online | Health - March 9, 2022 Category: Consumer Health News Source Type: news
